2010 | Lamivudine maintenance beyond one year after HBeAg seroconversion is a major factor for sustained virologic response in HBeAg-positive chronic hepatitis B | HEPATOLOGY |
2012 | Lamivudine plus adefovir vs. entecavir in HBeAg-positive hepatitis B with sequential treatment failure of lamivudine and adefovir. | LIVER INTERNATIONAL |
2021 | Lenvatinib is independently associated with the reduced risk of progressive disease when compared with sorafenib in patients with advanced hepatocellular carcinoma | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
2017 | Less Fibrotic Burden Differently Affects the Long-Term Outcomes of Hepatocellular Carcinoma after Curative Resection. | ONCOLOGY |
2019 | Liver Cirrhosis, Not Antiviral Therapy, Predicts Clinical Outcome in Cohorts with Heterogeneous Hepatitis B Viral Status
| GUT AND LIVER |
2017 | Liver fibrosis assessed with transient elastography is an independent risk factor for ischemic stroke | ATHEROSCLEROSIS |
2019 | Liver Fibrosis, Not Steatosis, Associates with Long-Term Outcomes in Ischaemic Stroke Patients | CEREBROVASCULAR DISEASES |
2009 | Liver stiffness measurement in combination with noninvasive markers for the improved diagnosis of B-viral liver cirrhosis. | JOURNAL OF CLINICAL GASTROENTEROLOGY |
2012 | Liver stiffness measurement using acoustic radiation force impulse (ARFI) elastography and effect of necroinflammation. | DIGESTIVE DISEASES AND SCIENCES |
2009 | Liver stiffness measurement using FibroScan is influenced by serum total bilirubin in acute hepatitis | LIVER INTERNATIONAL |
2014 | Liver Stiffness Value-Based Risk Estimation of Late Recurrence after Curative Resection of Hepatocellular Carcinoma: Development and Validation of a Predictive Model
| PLOS ONE |
2015 | Liver stiffness-based model for prediction of hepatocellular carcinoma in chronic hepatitis B virus infection: comparison with histological fibrosis | LIVER INTERNATIONAL |
2021 | Liver Stiffness-Based Risk Prediction Model for Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease
| CANCERS |
2020 | Liver-directed combined radiotherapy as a bridge to curative surgery in locally advanced hepatocellular carcinoma beyond the Milan criteria | RADIOTHERAPY AND ONCOLOGY |
2022 | Liver-Directed Concurrent Chemoradiotherapy versus Sorafenib in Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis
| CANCERS |
2022 | Liver-directed concurrent chemoradiotherapy versus sorafenib in hepatocellular carcinoma with portal vein tumor thrombus | JOURNAL OF CLINICAL ONCOLOGY |
2010 | Long-term adefovir dipivoxil monotherapy for up to 5 years in lamivudine-resistant chronic hepatitis B
| ANTIVIRAL THERAPY |
2014 | Long-term changes of liver stiffness values assessed using transient elastography in patients with chronic hepatitis B receiving entecavir | LIVER INTERNATIONAL |
2005 | Long-term clinical outcome of large volume paracentesis with intravenous albumin in patients with spontaneous bacterial peritonitis: A randomized prospective study | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
2011 | Long-term clinical outcomes of hepatic arterial infusion chemotherapy with cisplatin with or without 5-fluorouracil in locally advanced hepatocellular carcinoma. | JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY |
2022 | Long-term effects of entecavir and tenofovir treatment on the fibrotic burden in patients with chronic hepatitis B | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
2017 | Long-Term Follow-Up of Patients After Autologous Bone Marrow Cell Infusion for Decompensated Liver Cirrhosis
| CELL TRANSPLANTATION |
2014 | Long-term outcomes of chronic hepatitis B virus infection in the era of antiviral therapy in Korea | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
2022 | Long-term renal safety between patients with chronic hepatitis B receiving tenofovir vs. entecavir therapy: A multicenter study | JOURNAL OF VIRAL HEPATITIS |
2019 | Longitudinal assessment of alpha-fetoprotein for early detection of hepatocellular carcinoma in patients with cirrhosis | SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY |
2015 | Lower incidence of hepatocellular carcinoma and cirrhosis in hepatitis C patients with sustained virological response by pegylated interferon and ribavirin | DIGESTIVE DISEASES AND SCIENCES |
2022 | Lung and lymph node metastases from hepatocellular carcinoma: Comparison of pathological aspects | LIVER INTERNATIONAL |
2023 | MAFLD might be better in identifying subjects with sarcopenia or cardiovascular risk than NAFLD: A nationwide study | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
2014 | Maintaining remission in lamivudine-resistant patients with a virological response to adefovir add-on lamivudine after stopping lamivudine therapy. | LIVER INTERNATIONAL |
2008 | MDM2 and p53 polymorphisms are associated with the development of hepatocellular carcinoma in patients with chronic hepatitis B virus infection
| CARCINOGENESIS |
2021 | Measuring radiation exposure of operators engaged in the yttrium-90 microsphere radioembolization treatment of hepatocellular carcinoma patients | OPTIK |
2011 | MELD-based indices as predictors of mortality in chronic liver disease patients who undergo emergency surgery with general anesthesia | JOURNAL OF GASTROINTESTINAL SURGERY |
2021 | Metabolic activity assessment by 18 F-fluorodeoxyglucose positron emission tomography in patients with hepatocellular carcinoma undergoing Yttrium-90 transarterial radioembolization | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
2023 | Metabolic dysfunction associated fatty liver disease identifies subjects with cardiovascular risk better than non-alcoholic fatty liver disease | LIVER INTERNATIONAL |
2019 | Multicenter Retrospective Risk Assessment of Esophageal Variceal Bleeding in Patients with Cirrhosis: An Acoustic Radiation Force Impulse Elastography-Based Prediction Model
| GUT AND LIVER |
2008 | Natural history of hepatitis B virus-related cirrhotic patients hospitalized to control ascites | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
2020 | Natural History of Untreated HBeAg-Positive Chronic HBV Infection With Persistently Elevated HBV DNA but Normal Alanine Aminotransferase | CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY |
2021 | Negligible risks of hepatocellular carcinoma during biomarker-defined immune-tolerant phase for patients with chronic hepatitis B
| CLINICAL AND MOLECULAR HEPATOLOGY |
2024 | Neither hepatic steatosis nor fibrosis is associated with clinical outcomes in patients with intestinal Behçet’s disease | EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY |
2010 | New automated hepatitis C virus (HCV) core antigen assay as an alternative to real-time PCR for HCV RNA quantification
| JOURNAL OF CLINICAL MICROBIOLOGY |
2021 | No influence of hepatic steatosis on the 3-year outcomes of patients with quiescent chronic hepatitis B | JOURNAL OF VIRAL HEPATITIS |
2010 | Non-invasive assessment of changes in liver fibrosis via liver stiffness measurement in patients with chronic hepatitis B: impact of antiviral treatment on fibrosis regression
| HEPATOLOGY INTERNATIONAL |
2014 | Non-invasive diagnosis of hepatitis B virus-related cirrhosis
| WORLD JOURNAL OF GASTROENTEROLOGY |
2020 | Nonalcoholic Fatty Liver Disease and Sarcopenia Are Independently Associated With Cardiovascular Risk | AMERICAN JOURNAL OF GASTROENTEROLOGY |
2018 | Noncontrast magnetic resonance imaging versus ultrasonography for hepatocellular carcinoma surveillance (MIRACLE-HCC): study protocol for a prospective randomized trial
| BMC CANCER |
2023 | Noninvasive risk assessment of hepatic decompensation in patients with hepatitis B virus-related liver cirrhosis | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
2015 | Normal controlled attenuation parameter values: a prospective study of healthy subjects undergoing health checkups and liver donors in Korea | DIGESTIVE DISEASES AND SCIENCES |
2013 | Normal enhanced liver fibrosis (ELF) values in apparently healthy subjects undergoing a health check-up and in living liver donors in South Korea | LIVER INTERNATIONAL |
2012 | Normal liver elasticity values using acoustic radiation force impulse imaging: a prospective study in healthy living liver and kidney donors | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
2012 | "Normal" liver stiffness values differ between men and women: a prospective study for healthy living liver and kidney donors in a native Korean population | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
2021 | Novel Liver Stiffness-Based Nomogram for Predicting Hepatocellular Carcinoma Risk in Patients with Chronic Hepatitis B Virus Infection Initiating Antiviral Therapy
| CANCERS |
2013 | Number of target lesions for EASL and modified RECIST to predict survivals in hepatocellular carcinoma treated with chemoembolization
| CLINICAL CANCER RESEARCH |
2020 | Optimal sequence of systemic therapy after sorafenib failure in patients with hepatocellular carcinoma
| CLINICAL AND MOLECULAR HEPATOLOGY |
2012 | Optimal time for restoring the reliability of liver stiffness measurement in patients with chronic hepatitis B experiencing acute exacerbation | JOURNAL OF CLINICAL GASTROENTEROLOGY |
2013 | Optimal timing of combining sorafenib with locoregional treatments in patients with advanced hepatocellular carcinoma | EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY |
2013 | Orthotopic liver transplantation after the combined use of locoregional therapy and sorafenib for advanced hepatocellular carcinoma
| ONCOTARGETS AND THERAPY |
2009 | Outcome after curative resection for a huge (≥10 cm) hepatocellular carcinoma and prognostic significance of gross tumor classification | AMERICAN JOURNAL OF SURGERY |
2016 | Outcome of adefovir add-on lamivudine rescue therapy of up to 5 years in patients with lamivudine-resistant chronic hepatitis B | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
2013 | Partial Virological Response to Adefovir Add-On Lamivudine Rescue Therapy in Patients with Lamivudine-Resistant Chronic Hepatitis B | DIGESTION |
2011 | Partial virological response to entecavir in treatment-naive patients with chronic hepatitis B. | ANTIVIRAL THERAPY |